Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1519176 (
PSA
)
5,490
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Evidence is presented that a differentiated mesodermal line (MES-1) from P19 EC cells express a high chemotactic response to
platelet-derived growth factor
(
PDGF
) as assayed in a blind-well modified Boyden chamber. Compared to the NIH 3T3 fibroblasts the chemotactic response of MES-1 is increased by 10-fold at 0.3 ng/ml of
PDGF
, 4-fold at 1.25 ng/ml of
PDGF
, 2-fold at 2.5 ng/ml of
PDGF
. In contrast,
PDGF
induces the same increase in [3H]thymidine incorporation in both cell lines, made quiescent under reduced serum concentration. This high chemotactic response to
PDGF
seems specific for these mesodermal cells. Among the different teratocarcinoma cells tested, including stem cells (F9, PC 13, PCC4) and endodermal derivatives (PYS, F9 with retinoic acid,
PSA
5E), only the visceral endodermlike cells (PSA5E) are slightly attracted by
PDGF
. This chemotactic response to
PDGF
is not related to the presence or characteristics of the type B
PDGF
receptors, which are less numerous in MES-1 cells (10(5) receptors/cell, KDa 1,2 mM) compared to NIH 3T3 cells (64 X 10(4) receptors per cell, KDa 1,8 nM). The MES-1 cell line might be of interest for studying the chemotactic effect of
PDGF
. These results also suggest a role for this soluble factor in cell migration during early embryogenesis.
...
PMID:High chemotactic response to platelet-derived growth factor of a teratocarcinoma differentiated mesodermal cell line. 216 Sep 26
Retinoic acid-induced differentiation of F9 embryonal carcinoma cells to endoderm provokes the secretion of a protein factor that acts as both a chemoattractant and mitogen for smooth muscle cells. Undifferentiated F9 cells and
PSA
-5E (visceral endodermlike) cells produced little of this factor. However, PYS-2 (parietal endodermlike) and Dif 5 endoderm cells were found to produce significant amounts of endoderm-derived mitoattractant (EDM) activity. The activity secreted by the Dif 5 cells was partially purified using gel filtration chromatography using chemotaxis and mitogenic assays as markers for biological activity. The partially purified activity competes with [125I]iodo-
platelet-derived growth factor
(
PDGF
) for binding to target cells, and the biological activity is neutralized with anti-
PDGF
IgG, suggesting shared domains in the two molecules. However, the factor appears to be different from
PDGF
, based on its thermal stability, molecular weight, and charge. The differentiated endoderm cells including retinoic acid (RA)-treated F9, Dif 5,
PSA
-5E, and PYS-2 cells also exhibit specific [125I]iodo-
PDGF
binding, and the
PSA
-5E cells respond to
PDGF
as a chemoattractant. Conceivably, such a
PDGF
-like factor may contribute to the regulation of cell growth and migration during the early stages of embryogenesis.
...
PMID:Differentiation-dependent production of a platelet-derived growth factor-like mitoattractant by endoderm cells derived from embryonal carcinoma cells. 283 23
In this report, we demonstrate that F9 and PC-13 embryonal carcinoma (EC) cells do not bind significant amounts of
platelet-derived growth factor
(
PDGF
), whereas the endoderm-like differentiated cells derived from EC cells do. The F9-differentiated cells exhibit approximately 8300 receptors per cell, with an apparent dissociation constant of 30 pM. Two endoderm-like cell lines,
PSA
-5E and PYS-2, also bind
PDGF
and exhibit approximately 4800 and 23,500 receptors per cell, respectively. The lack of
PDGF
binding by the parental EC cells is consistent with their release of a factor(s) that is closely related to
PDGF
. This factor(s) competes with
PDGF
for binding to membrane receptors and is recognized by antibodies raised against
PDGF
. However, this factor(s) does not appear to be antigenically identical to
PDGF
. We also show that production of this
PDGF
-like factor(s) is reduced more than 90% when F9 EC cells differentiate into cells that bind
PDGF
. Thus, our findings indicate that EC cells release a factor(s) that should be capable of binding to their differentiated cells. This raises the possibility that
PDGF
, or a closely related factor, can influence cell proliferation and/or cell behavior of early embryonic cells.
...
PMID:Production of PDGF-like growth factors by embryonal carcinoma cells and binding of PDGF to their endoderm-like differentiated cells. 298 42
Multipotent neural progenitor species present within developing and adult periventricular generative zones can give rise to all of the major cellular elements of the brain. Although lineage specification during development has been thought to be restricted to these generative zones, we have utilized quantitative immunoselection techniques to isolate an enriched population of multipotent neural progenitor cells that express polysialylated neural cell adhesion molecule (PSA-NCAM) from postnatal day 2 cerebral cortex independent of generative zones. This population of cerebral cortical progenitor cells exhibited robust proliferation in response to epidermal growth factor and subsequently gave rise to clonally derived neurons, astrocytes, and oligodendrocytes. Quantitative regional analysis further demonstrated that while the multipotent cells derived from the cerebral cortex uniformly expressed
PSA
-NCAM, multipotent cells derived from generative zones contained equal proportions of
PSA
-NCAM-positive and -negative multipotent progenitor cells. The generation of individual cellular lineages from cortical multipotent progenitors could be enhanced by specific cytokines that are expressed within the cerebral cortex. Further, while oligodendroglial progenitor cells derived from cortical multipotent progenitors exhibited responsiveness to
platelet-derived growth factor
(
PDGF
) and neurotrophin-3 (NT-3), primary cultures of cortical oligodendroglial progenitors were responsive to
PDGF
but not to NT-3. These observations suggest that in addition to glial progenitors that commit to a specific lineage prior to migration from generative zones, there is within the cerebral cortex a separate pool of multipotent cells that are capable of generating mature glial progeny in response to specific environmental cues. Therapeutic interventions aimed at differentiation of endogenous cerebral pools of multipotent progenitors may provide a novel strategy for amelioration of the sequelae of environmental and genetic insults to the postnatal cerebrum.
...
PMID:Isolation and developmental characterization of cerebral cortical multipotent progenitors. 988 91
Oligodendrocyte maturation is regulated by multiple secreted factors present in the brain during critical stages of development. Whereas most of these factors promote oligodendrocyte proliferation and survival, members of the bone morphogenetic protein family (BMPs) recently have been shown to inhibit oligodendrocyte differentiation in vitro. Oligodendrocyte precursors treated with BMPs differentiate to the astrocyte lineage. Given that cells at various stages of the oligodendrocyte lineage have distinct responses to growth factors, we hypothesized that the response to BMP would be stage-specific. Using highly purified, stage-specific cultures, we found that BMP has distinct effects on cultured oligodendrocyte preprogenitors, precursors, and mature oligodendrocytes. Oligodendrocyte preprogenitors (
PSA
-NCAM+, A2B5-) treated with BMP2 or BMP4 developed a novel astrocyte phenotype characterized by a morphological change and expression of glial fibrillary acidic protein (GFAP) but little glutamine synthetase expression and no labeling with A2B5 antibody. In contrast, treating oligodendrocyte precursors with BMPs resulted in the accumulation of cells with the traditional type 2 astrocyte phenotype (GFAP+, A2B5+). However, many of the cells with an astrocytic morphology did not express GFAP or glutamine synthetase unless thyroid hormone was present in the medium. The addition of fibroblast growth factor along with BMP to either oligodendrocyte preprogenitor or the oligodendrocyte precursor cells inhibited the switch to the astrocyte lineage, whereas
platelet-derived growth factor
addition had no effect. Treatment of mature oligodendrocytes with BMP elicited no change in morphology or expression of GFAP. These data suggest that as cells progress through the oligodendrocyte lineage, they show developmentally restricted responses to the BMPs.
...
PMID:Stage-specific effects of bone morphogenetic proteins on the oligodendrocyte lineage. 1075 62
The capacity of multipotential progenitor cells of the adult mammalian forebrain to generate myelin-forming oligodendrocytes was tested by grafting fragments of different regions of the subventricular zone (SVZ) of the lateral ventricle and the striatum of 6-month-old wild-type mice into the brain of neonate shiverer and wild-type mice. Without growth factor treatment, only few cells of the rostral SVZ survived and formed myelin after engraftment. Treating donors prior to transplantation with a single intraperitoneal injection of epidermal growth factor, basic fibroblast growth factor 2 (FGF-2), and
platelet-derived growth factor
AB (PDGF(AB)) vigorously promoted the survival, migration, and differentiation of the grafted SVZ cells into myelin-forming oligodendrocytes. In situ, both growth factors expanded the constitutively proliferative
PSA
-NCAM+ population and favored their differentiation toward the neuronal and oligodendroglial cell fate. The adult central nervous system thus harbors a focal reservoir of FGF-2 and PDGF(AB)-responsive cells which are able to generate substantial amounts of myelin-forming oligodendrocytes in vivo, opening a new prospective area for therapy in demyelinating diseases.
...
PMID:Fibroblast growth factor-2 (FGF-2) and platelet-derived growth factor AB (PDGF AB) promote adult SVZ-derived oligodendrogenesis in vivo. 1213 17
In the present work, we studied the effects of several growth factors on survival and proliferation of freshly isolated neural progenitors expressing the polysialylated form of neural cell adhesion molecule (PSA-NCAM). Cells were obtained from postnatal day 2 rat forebrain, using isolation method. We found that (1) insulin-like growth factor 1 (IGF-1) exerts a powerful survival effect by inhibiting apoptotic cell death, (2) epidermal growth factor (EGF) strongly increases cell proliferation, (3) the combination of IGF-1 plus EGF promotes cellular expansion, (4) basic fibroblast growth factor displays only a weak mitogenic effect, and (5)
platelet-derived growth factor
-AA (PDGF-AA) has no effect on cell survival and proliferation. These results suggest that the postnatal
PSA
-NCAM(+) progenitors characterized in the present work may represent a transitional stage, between the embryonic EGF-responsive neural progenitors and the postnatal
PSA
-NCAM(+) progenitors already described that are PDGF-responsive. For these "early
PSA
-NCAM(+) progenitors," insulin-like growth factor 1 and EGF seem to play a pivotal role in the control of cell death and cell proliferation.
...
PMID:Control of cell survival and proliferation of postnatal PSA-NCAM(+) progenitors. 1267 27
Directed migration of oligodendrocyte precursor cells (OPCs) is important for myelin formation and repair but the mechanisms of directional control are poorly understood. Here we have tested the role of polysialic acid-neural cell adhesion molecule (PSA-NCAM) in the directional migration of OPCs towards
platelet-derived growth factor
(
PDGF
). Using a Boyden microchemotaxis chamber and the Dunn direct viewing chamber, we show that in concentration gradients of
PDGF
,
PSA
-positive OPCs polarize and efficiently migrate towards the source of
PDGF
(chemotaxis). The loss or inactivation of the polysialic tail of NCAM leads to an altered pattern of OPC migration in response to
PDGF
gradients. Cells under these conditions, while being polarized and migrating, show no bias of displacement towards the source of
PDGF
and make random turns. By contrast, directed migration of OPCs towards basic fibroblast growth factor was not affected by the removal of
PSA
. Moreover, inactivation of
PSA
does not interfere with the random migration pattern of cells in uniform concentrations of
PDGF
(chemokinesis). These results suggest that
PSA
-NCAM is specifically involved in establishing the directionality of OPC migration in response to the concentration gradient of
PDGF
, but it is not essential for cell motility per se.
...
PMID:A role for the polysialic acid-neural cell adhesion molecule in PDGF-induced chemotaxis of oligodendrocyte precursor cells. 1462 27